These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20220782)

  • 1. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
    Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
    Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
    Noè F; Pool AH; Nissinen J; Gobbi M; Bland R; Rizzi M; Balducci C; Ferraguti F; Sperk G; During MJ; Pitkänen A; Vezzani A
    Brain; 2008 Jun; 131(Pt 6):1506-15. PubMed ID: 18477594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.
    Richichi C; Lin EJ; Stefanin D; Colella D; Ravizza T; Grignaschi G; Veglianese P; Sperk G; During MJ; Vezzani A
    J Neurosci; 2004 Mar; 24(12):3051-9. PubMed ID: 15044544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
    Foti S; Haberman RP; Samulski RJ; McCown TJ
    Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
    Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
    Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.
    Sørensen AT; Nikitidou L; Ledri M; Lin EJ; During MJ; Kanter-Schlifke I; Kokaia M
    Exp Neurol; 2009 Feb; 215(2):328-33. PubMed ID: 19038255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
    Sørensen AT; Kanter-Schlifke I; Carli M; Balducci C; Noe F; During MJ; Vezzani A; Kokaia M
    Hippocampus; 2008; 18(6):564-74. PubMed ID: 18306304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
    Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
    Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
    Ledri LN; Melin E; Christiansen SH; Gøtzsche CR; Cifra A; Woldbye DP; Kokaia M
    Neurobiol Dis; 2016 Feb; 86():52-61. PubMed ID: 26607785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures.
    Melin E; Andersson M; Gøtzsche CR; Wickham J; Huang Y; Szczygiel JA; Boender A; Christiansen SH; Pinborg L; Woldbye DPD; Kokaia M
    Gene Ther; 2023 Aug; 30(7-8):649-658. PubMed ID: 37029201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure suppression by GDNF gene therapy in animal models of epilepsy.
    Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
    Mol Ther; 2007 Jun; 15(6):1106-13. PubMed ID: 17387333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.
    Weinberg MS; Blake BL; Samulski RJ; McCown TJ
    Gene Ther; 2011 Oct; 18(10):961-8. PubMed ID: 21490684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
    Woldbye DP; Angehagen M; Gøtzsche CR; Elbrønd-Bek H; Sørensen AT; Christiansen SH; Olesen MV; Nikitidou L; Hansen TV; Kanter-Schlifke I; Kokaia M
    Brain; 2010 Sep; 133(9):2778-88. PubMed ID: 20688813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
    Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
    Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure-suppressant actions of prepro-NPY overexpression in male rats.
    Soud K; Jørgensen SH; Woldbye DPD; Sørensen AT
    J Neurosci Res; 2019 Mar; 97(3):362-372. PubMed ID: 30367522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.
    Lin EJ; Richichi C; Young D; Baer K; Vezzani A; During MJ
    Eur J Neurosci; 2003 Oct; 18(7):2087-92. PubMed ID: 14622242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints.
    Mason JB; Gurda BL; Engiles JB; Hankenson KD; Wilson JM; Richardson DW
    Hum Gene Ther Methods; 2013 Jun; 24(3):185-94. PubMed ID: 23659250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.
    Olesen MV; Christiansen SH; Gøtzsche CR; Nikitidou L; Kokaia M; Woldbye DP
    J Neurosci Res; 2012 Feb; 90(2):498-507. PubMed ID: 21971867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y overexpression using recombinant adeno-associated viral vectors.
    Noé F; Frasca A; Balducci C; Carli M; Sperk G; Ferraguti F; Pitkänen A; Bland R; Fitzsimons H; During M; Vezzani A
    Neurotherapeutics; 2009 Apr; 6(2):300-6. PubMed ID: 19332323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.